Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001658367-19-000002
Filing Date
2019-11-20
Accepted
2019-11-20 16:31:17
Documents
1
Effectiveness Date
2019-11-20
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11020
  Complete submission text file 0001658367-19-000002.txt   12080
Mailing Address 230 E 15TH STREET SUITE 1-A NEW YORK NY 10003
Business Address 230 E 15TH STREET SUITE 1-A NEW YORK NY 10003 917-913-8511
ILIAD BIOTECHNOLOGIES, LLC (Filer) CIK: 0001658367 (see all company filings)

EIN.: 454419429 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-353871 | Film No.: 191234594